493 related articles for article (PubMed ID: 28910741)
1. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
Leitsch D
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):321-327. PubMed ID: 28910741
[TBL] [Abstract][Full Text] [Related]
2. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites.
Cedillo-Rivera R; Chávez B; González-Robles A; Tapia A; Yépez-Mulia L
J Eukaryot Microbiol; 2002; 49(3):201-8. PubMed ID: 12120985
[TBL] [Abstract][Full Text] [Related]
3. Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis.
Jarrad AM; Debnath A; Miyamoto Y; Hansford KA; Pelingon R; Butler MS; Bains T; Karoli T; Blaskovich MA; Eckmann L; Cooper MA
Eur J Med Chem; 2016 Sep; 120():353-62. PubMed ID: 27236016
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.
Adagu IS; Nolder D; Warhurst DC; Rossignol JF
J Antimicrob Chemother; 2002 Jan; 49(1):103-11. PubMed ID: 11751773
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp.
Upcroft JA; Campbell RW; Benakli K; Upcroft P; Vanelle P
Antimicrob Agents Chemother; 1999 Jan; 43(1):73-6. PubMed ID: 9869568
[TBL] [Abstract][Full Text] [Related]
6. Highly Potent 1
Kumar S; Bains T; Won Kim AS; Tam C; Kim J; Cheng LW; Land KM; Debnath A; Kumar V
Front Cell Infect Microbiol; 2018; 8():380. PubMed ID: 30425970
[TBL] [Abstract][Full Text] [Related]
7. Drug targets and mechanisms of resistance in the anaerobic protozoa.
Upcroft P; Upcroft JA
Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
[TBL] [Abstract][Full Text] [Related]
8. Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent.
Capparelli EV; Bricker-Ford R; Rogers MJ; McKerrow JH; Reed SL
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821451
[TBL] [Abstract][Full Text] [Related]
9. Drug susceptibility testing of anaerobic protozoa.
Upcroft JA; Upcroft P
Antimicrob Agents Chemother; 2001 Jun; 45(6):1810-4. PubMed ID: 11353630
[TBL] [Abstract][Full Text] [Related]
10. Redox Pathways as Drug Targets in Microaerophilic Parasites.
Leitsch D; Williams CF; Hrdý I
Trends Parasitol; 2018 Jul; 34(7):576-589. PubMed ID: 29807758
[TBL] [Abstract][Full Text] [Related]
11. Reprofiled drug targets ancient protozoans: drug discovery for parasitic diarrheal diseases.
Debnath A; Ndao M; Reed SL
Gut Microbes; 2013; 4(1):66-71. PubMed ID: 23137963
[TBL] [Abstract][Full Text] [Related]
12. Comparison between two common methods for measuring Giardia lamblia susceptibility to antiparasitic drugs in vitro.
Cruz A; Isaura Sousa M; Azeredo Z; Carolina Silva M; Figueiredo de Sousa JC; Manso O; Cabral M
Acta Trop; 2003 Oct; 88(2):131-5. PubMed ID: 14516924
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antiprotozoal activity, and chemoinformatic analysis of 2-(methylthio)-1H-benzimidazole-5-carboxamide derivatives: Identification of new selective giardicidal and trichomonicidal compounds.
Flores-Carrillo P; Velázquez-López JM; Aguayo-Ortiz R; Hernández-Campos A; Trejo-Soto PJ; Yépez-Mulia L; Castillo R
Eur J Med Chem; 2017 Sep; 137():211-220. PubMed ID: 28595066
[TBL] [Abstract][Full Text] [Related]
14. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis.
Upcroft JA; Dunn LA; Wright JM; Benakli K; Upcroft P; Vanelle P
Antimicrob Agents Chemother; 2006 Jan; 50(1):344-7. PubMed ID: 16377707
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the in vitro effect of albendazole, metronidazole and nitazoxanide on viability and structure of Giardia lamblia cysts.
Bernal-Redondo R; Martínez-Méndez LG; Mendoza-Chavez A; Velasco-Perales D; Chavez-Munguia B
J Submicrosc Cytol Pathol; 2004; 36(3-4):241-5. PubMed ID: 15906598
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 3-tetrazolylmethyl-4H-chromen-4-ones via Ugi-azide and biological evaluation against Entamoeba histolytica, Giardia lamblia and Trichomona vaginalis.
Cano PA; Islas-Jácome A; González-Marrero J; Yépez-Mulia L; Calzada F; Gámez-Montaño R
Bioorg Med Chem; 2014 Feb; 22(4):1370-6. PubMed ID: 24468633
[TBL] [Abstract][Full Text] [Related]
17. Metronidazole-triazole conjugates: activity against Clostridium difficile and parasites.
Jarrad AM; Karoli T; Debnath A; Tay CY; Huang JX; Kaeslin G; Elliott AG; Miyamoto Y; Ramu S; Kavanagh AM; Zuegg J; Eckmann L; Blaskovich MA; Cooper MA
Eur J Med Chem; 2015 Aug; 101():96-102. PubMed ID: 26117821
[TBL] [Abstract][Full Text] [Related]
18. A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia.
Tejman-Yarden N; Miyamoto Y; Leitsch D; Santini J; Debnath A; Gut J; McKerrow JH; Reed SL; Eckmann L
Antimicrob Agents Chemother; 2013 May; 57(5):2029-35. PubMed ID: 23403423
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target.
Leitsch D; Müller J; Müller N
Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):148-153. PubMed ID: 27485086
[TBL] [Abstract][Full Text] [Related]
20. Antiprotozoal activity of proton-pump inhibitors.
Pérez-Villanueva J; Romo-Mancillas A; Hernández-Campos A; Yépez-Mulia L; Hernández-Luis F; Castillo R
Bioorg Med Chem Lett; 2011 Dec; 21(24):7351-4. PubMed ID: 22047694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
